Sulbenicillin Sodium

Sulbenicillin Sodium (CAS No.: 28002-18-8) is a semisynthetic sulfobenzyl penicillin class antibacterial reagent used in life sciences as a beta lactam probe for studies of bacterial cell wall biogenesis, antimicrobial susceptibility, and resistance evolution, with primary activity associated with covalent acylation of penicillin binding proteins involved in peptidoglycan crosslinking and consequent disruption of cell envelope integrity in susceptible organisms, particularly among Gram negative bacilli including Pseudomonas aeruginosa relevant laboratory strains; in addition to canonical beta lactam pharmacology, published experimental observations indicate suppression of platelet functional responses under in vitro conditions, including inhibition of primary and secondary aggregation, reduced serotonin release, and decreased platelet adhesion, supporting use as a tool compound for interrogating platelet activation biology in mechanistic settings rather than for non research purposes, while pathway level interpretation generally maps antibacterial effects to peptidoglycan assembly networks and stress responses linked to envelope damage and beta lactam resistance determinants; when explicit assay constants are not uniformly reported for all organisms and systems, activity is commonly represented in microbiology workflows by minimum inhibitory concentration testing that often falls within micromolar equivalent exposure ranges depending on species, inoculum, and medium composition, and in cell based platelet studies by concentration dependent effects spanning experimentally defined low to moderate ranges, with exact concentrations or doses selected according to specific experimental designs, comparator controls, and research objectives in compound profiling, infection model development, and translational drug discovery screening platforms.